Personalized Medicine Gets Boost With New Prostate Cancer Finding
In a breakthrough with implications for new therapies, scientists have discovered five groups of prostate cancer, each with different DNA signatures.
In a breakthrough with implications for new therapies, scientists have discovered five groups of prostate cancer, each with different DNA signatures. That discovery means patients may get more customized treatment plans that will try to tackle their subtype. It’s another step toward personalized medicine and a shift from a one-size-fits-all treatment approach. (The Washington Post)
Quality journalism doesn't come free
Perhaps it goes without saying — but producing quality journalism isn't cheap. At a time when newsroom resources and revenue across the country are declining, The Texas Tribune remains committed to sustaining our mission: creating a more engaged and informed Texas with every story we cover, every event we convene and every newsletter we send. As a nonprofit newsroom, we rely on members to help keep our stories free and our events open to the public. Do you value our journalism? Show us with your support.Yes, I'll donate today